Industry Profile
Regenerative Medicine
Target researchers — Tissue engineers, biomaterials scientists, and cell biologists specializing in scaffold fabrication, organ-on-chip systems, decellularized ECM, 3D bioprinting, and stem cell differentiation into tissue-specific lineages
Regenerative medicine replaces or repairs damaged tissues using scaffolds, cells, and growth factors. Academic biomaterials and stem cell groups are key IP sources for decellularized ECM products, injectable hydrogels, and organoid platforms that companies license for wound care, orthopedics, and organ repair applications.
Key Companies
Use Cases
Biomaterial scaffold licensing
Organoid model co-development
3D bioprinting platform partnerships
ECM-derived product supply
Wound healing biology research
Stem cell differentiation protocol transfer
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →